Imaging	O
tumor	B-Cancer
angiogenesis	O
.	O

Since	O
the	O
discovery	O
of	O
vascular	B-Multi-tissue_structure
-	O
specific	O
growth	O
factors	O
with	O
angiogenic	O
activity	O
,	O
there	O
has	O
been	O
a	O
significant	O
effort	O
to	O
develop	O
cancer	B-Cancer
drugs	O
that	O
restrict	O
tumorigenesis	O
by	O
targeting	O
the	O
blood	B-Organism_substance
supply	O
.	O

In	O
this	O
issue	O
of	O
the	O
JCI	O
,	O
Mancuso	O
et	O
al	O
.	O
use	O
mouse	O
models	O
to	O
better	O
understand	O
the	O
plasticity	O
of	O
the	O
tumor	B-Multi-tissue_structure
vasculature	I-Multi-tissue_structure
in	O
the	O
face	O
of	O
antiangiogenic	O
therapy	O
(	O
see	O
the	O
related	O
article	O
beginning	O
on	O
page	O
2610	O
)	O
.	O

They	O
describe	O
a	O
rapid	O
regrowth	O
of	O
the	O
tumor	B-Multi-tissue_structure
vasculature	I-Multi-tissue_structure
following	O
withdrawal	O
of	O
VEGFR	O
inhibitors	O
,	O
emphasizing	O
the	O
importance	O
of	O
fully	O
understanding	O
the	O
function	O
of	O
these	O
and	O
similar	O
treatments	O
used	O
in	O
the	O
clinic	O
at	O
the	O
cellular	B-Cell
and	O
molecular	O
level	O
.	O

